Add BrightSurf on Google Email

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

Researchers at Beth Israel Deaconess Medical Center discovered that specific genetic events drive distinct immune cell compositions in primary prostate tumors, dictating tumor progression and response to therapy. Profiling patients' tumors based on this new information could lead to more successful clinical trials and tailored therapies.

SourceBeth Israel Deaconess Medical Center·JournalNature Medicine·DateJan 12, 2018

Why are minorities underrepresented in genetic cancer studies?

A study published in Journal of Cancer Survivorship found that motivation to provide samples for genetic tests depends on oncologist engagement or religion, rather than race. Women with better access to healthcare and a greater sense of well-being were more likely to participate in genetic research.

SourceSpringer·JournalJournal of Cancer Survivorship·DateNov 16, 2017

Zipping DNA

Researchers at ETH Zurich have developed a method to compress and decompress DNA, enabling the efficient transfer of large amounts of genetic information into cells. This innovation has potential applications in synthetic biology, biotechnology, and cancer research, improving diagnosis accuracy and treatment outcomes.

SourceETH Zurich·JournalNature Nanotechnology·DateNov 13, 2017

Researchers find low genetic diversity in domestic ferrets

Researchers discovered low genetic diversity in domestic ferrets globally, making them more susceptible to diseases and disorders. The study highlights the importance of incorporating genetically diverse ferrets from other countries into breeding programs to minimize inbreeding and reduce the risk of disease transmission.

SourceUniversity of Wyoming·JournalEvolutionary Applications·DateNov 1, 2017

The right way to repair DNA

Researchers found that tiny protein CYREN inhibits fast but error-prone NHEJ pathway and enables slower HR pathway, offering potential tool against cancer. CYREN's discovery clarifies longstanding mystery about DNA repair pathways.

SourceSalk Institute·JournalNature·DateSep 20, 2017

New research points to potential for more targeted treatments of neuroblastoma tumors

Research at the University of Chicago Medical Center identified genetic variations that pre-dispose children to severe forms of neuroblastoma, paving the way for more targeted treatments. Children with MYCN-amplified tumors have a lower survival rate, but understanding their genetic predispositions could lead to more effective therapies.

SourceUniversity of Chicago Medical Center·JournalJNCI Journal of the National Cancer Institute·DateJun 19, 2017

Defective intercellular connections cause hydrocephalus

Research by the German Cancer Research Center has found that defective intercellular connections in the ependyma, a cellular layer separating the brain nervous tissue from CSF, cause hydrocephalus. This leads to blockage of the aqueduct, blocking cerebrospinal fluid flow and resulting in swollen heads and brain pressure.